Merck picks circular path to RNA and commits $250M to biotech startup Orna
Merck aims to bolster its genetic medicines pipeline through a new research alliance with Orna Therapeutics, a startup whose technology forms RNA into a circle […]
Infectious Diseases
With monkeypox, profits are once again being put ahead of protecting life | Nick Dearden
As with Covid, corporate interests are taking priority over getting vaccines to people and areas that most need them Two weeks ago I queued for […]
How the WHO hepatitis strategy measures up in the field
According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection. Africa is the […]
Basilea preps key US filing for MRSA antibiotic ceftobiprole
Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years after its first attempt was turned down […]
GSK pledges £1bn drive for infectious disease R&D
GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious diseases that mainly impact lower-income countries. The […]
The WTO faces a make or break week over vaccines | Larry Elliott
A ruling on whether or not to waive patent rules will this week show if the trade body is for the world or the west […]
2nd Annual mRNA-Based Therapeutics Summit
Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28. Expect exclusive data from […]
Vaccine to stop Covid transmission should now be top priority, says leading UK scientist
Oxford University’s Sir John Bell says sharp fall in death rate due to existing vaccines allows for a change in priorities It is questionable how […]
Readout sets up phase 3 for Valneva/Pfizer’s Lyme disease jab
There’s only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer’s VLA15 – and it has just moved another […]
Cidara and Mundipharma prep filings for antifungal rezafungin
Mundipharma and Cidara Therapeutics have reported the results of a phase 3 trial of their new once-weekly antifungal rezafungin, setting up regulatory filings in the […]
Oxford Covid jab gears up for final act: saving the rest of the world
After mishaps and misinformation, jab will build ‘global wall of immunity’, says director of Oxford Vaccine Group Exactly two years ago Prof Sir Andrew Pollard […]
AstraZeneca’s Evusheld Covid-prevention drug gets UK approval
Treatment aimed at people who cannot be vaccinated is boost to firm’s coronavirus portfolio AstraZeneca has received UK regulatory approval for its long-acting Covid-19 antibody […]
Global powers inch closer to agreement to waive Covid vaccine patents
The move would allow for cheaper generic versions to be manufactured and distributed among developing nations faster Follow our Australia news live blog for the […]
Harry and Meghan add voices to fierce critique of west’s Covid vaccine policies
Pair join Gordon Brown and 126 others in attack on ‘self-defeating nationalism, pharmaceutical monopolies and inequality’ Prince Harry and Meghan, the actor Charlize Theron and […]
The Covid treatment pill is here – and big pharma will ultimately decide who gets it | Othoman Mellouk
Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last Covid-19 has […]
Will Microbes Finally Force Modernization of the American Health Care System?
Mike Magee MD Science has a way of punishing humans for their arrogance. In 1996, Dr. Michael Osterholm found himself rather lonely and isolated in […]
The Protein Degradation & Targeting Undruggables Congress
The 3rd Protein Degradation and Targeting Undruggables Summit is North America’s only in-person, industry-led conference covering clinical progress and commercial scale development of first-in-class degrader […]
The Guardian view on vaccine justice: the developing world won’t wait | Editorial
Only one in four African healthcare workers is protected. Regional production and patent waivers are needed No one asked for generosity – only justice. Self-interest […]
Lifting England Covid rules while 3bn people unvaccinated reckless – experts
Scientists warn Boris Johnson that failure means new Covid variants will put thousands of lives at risk across UK Coronavirus – latest updates See all […]
How antivirals provide hope to vulnerable Covid patients
Pfizer says its recently approved Paxlovid drug has almost 90% success in preventing severe illness if taken soon after infection The recent decision by regulators […]
Wellcome Trust to spend £16bn on research with focus on Covid vaccines
Britain’s biggest charity announces spending plan over next decade after record return on investments Coronavirus – latest updates See all our coronavirus coverage The Wellcome […]
UK medicines regulator approves Pfizer’s ‘life-saving’ Covid pill
Paxlovid found to be ‘safe and effective’ at reducing hospitalisation and death among vulnerable adults Coronavirus – latest updates See all our coronavirus coverage UK […]
More options for Covid treatments in January as FDA approves two antiviral pills
The approval comes as reports of shortages in monoclonal antibody treatment arise and cases spike People at greater risk of becoming seriously ill from Covid-19 […]
Steps taken to target Omicron with AstraZeneca jab, scientist says
Sandy Douglas, from Oxford University, says updated vaccine could ‘respond to any new variant more rapidly’ Coronavirus – latest updates See all our coronavirus coverage […]
Covid will not be our last global health crisis – we need a long-term plan | Jeff Sparrow
It’s nearly inevitable that we will face another pandemic. If we don’t plan to counter it, tomorrow will be like today, except much, much worse […]
Is there any good news at all on Omicron? Yes, there are small signs of hope
Analysis: scientists are only starting to understand new Covid mutation but there is encouraging news from the laboratory, South Africa and on antiviral drugs Coronavirus […]
PCR travel tests need better policing, warns ex-watchdog boss Andrew Tyrie
Former CMA chair calls for enforcement of at least minimum standards in sector which is becoming ‘a massive rip-off’ Poor service from suppliers of PCR […]
Improving Outcomes: Key Post-Acute Trends in 2022
<div class="right-align"> <a class="btn btn-blue _gt" data-category="Hospital" data-action="Click-Button" data-label="Blog-Improving Outcomes- Key Post-Acute Trends in 2022" href="https://www.kindredhealthcare.com/docs/default-source/default-document-library/hd-improving-outcomes-2022-trends.pdf?sfvrsn=77dc66e9_2" title="Improving Outcomes: Key Post-Acute Trends in 2022" target="_blank">Download this […]
GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on
Early trials show jab effective in people of all ages who have already received doses of any vaccine Coronavirus – latest updates See all our […]
As Covid mutates, the vaccine makers are adapting too
Focus on the exciting potential of T-cell immunity is spurring the sector on to create a new generation of jabs The speed at which scientists […]
‘Wall of secrecy’ in Pfizer contracts as company accused of profiteering
US company faces scrutiny over Covid profits after UK agrees to secrecy clause Coronavirus – latest updates See all our coronavirus coverage Ministers have agreed […]
Covid: scientists find possible trigger for AstraZeneca jab blood clots
Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemic Coronavirus – latest updates See all our coronavirus […]
UK ministers secure 114m more Covid vaccines for next two years
Extra Pfizer/BioNTech and Moderna jabs for 2022 and 2023 ordered to ‘future proof’ vaccine programme Coronavirus – latest updates See all our coronavirus coverage Ministers […]
Prince Harry compares Covid vaccine inequity to HIV struggle
Duke of Sussex says on World Aids Day that vaccinating the world against Covid is ‘test of our moral character’ Coronavirus – latest updates See […]
The Omicron variant reveals the true global danger of ‘vaccine apartheid’
Sharing vaccines with poorer countries is the right thing and the self-interested thing to do. The west needs to stop being so short-sighted Mandatory face […]
Boris Johnson ‘ignored’ my plan to tackle deadly Covid variants – senior official
Former head of vaccine taskforce says No 10 has not acted on his blueprint to prepare UK for new strains Coronavirus – latest updates See […]
New HIV jabs taken two months apart hailed as huge step forward
Safe injectable antiretroviral drugs, approved by health bodies, ‘could lift burden of daily oral therapy’ Thousands of people living with HIV in Britain are to […]
UK firm to trial T-cell Covid vaccine that could give longer immunity
Exclusive: Oxfordshire-based Emergex gets go-ahead for trials in Switzerland for skin patch vaccine Coronavirus – latest updates See all our coronavirus coverage An Oxfordshire-based company […]
AstraZeneca’s new Covid treatment: what is it and how does it work?
Evusheld could offer higher protection against variants and help vulnerable people ward off virus Follow our Australia news live blog for the latest updates Five […]
Pfizer Covid pills highly effective at preventing deaths, trial suggests
Antiviral pill taken at home can cut rate of hospital admission and death by nearly 90%, says drugmaker Coronavirus – latest updates See all our […]
Local Covid vaccines fill gap as UN Covax scheme misses target
India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown […]
Pfizer asks US to allow Covid vaccines for children ages five to 11
Jabs could begin within weeks if US government approves request, with children getting a third of dose given to adults Pfizer asked the US government […]
3rd Inflammasome Therapeutics Summit
Discover the Intricacies of Inflammasome Regulation, Leverage Inflammasome Proteins as Biomarkers & Accelerate Novel Inflammasome Therapeutics into Proof-Of-Concept Clinical Trials & Beyond Built with Ventus […]
Coronavirus treatments: the potential ‘game-changers’ in development
After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promise Coronavirus – latest updates See all our coronavirus coverage […]
Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty
Six companies warned not to put profit before lives as report shows less than 1% of almost 6bn doses have gone to low-income countries Amnesty […]
BioNTech to seek approval for Covid jabs for younger children
Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus […]
Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands
Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects Coronavirus – latest updates See all […]
Taking a de-centralized approach to cure the Hepatitis C epidemic
This year’s World Hepatitis Day theme, ‘Hepatitis Can’t Wait,’ stresses the urgency of testing and treating viral hepatitis, as well as removing the stigma surrounding […]
UK approves rollout of ‘first of its kind’ Covid antibody treatment
Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines […]
A New Antibody-Dependent Enhancement Hypothesis
Here’s another post that I will regret writing, but a great many people have asked me about a new preprint that brings up the possibility […]
UK orders extra Covid vaccines for autumn 2022 booster campaign
Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited Coronavirus – latest updates See all our coronavirus […]
Viral Knots
The current pandemic has made everyone think a lot more about viruses than they ever had any desire to, but they’re a constant background to […]
As Delta spreads, Pfizer and Moderna get set for a booster shot to profits
The firms are already taking the lion’s share of earnings from the market, as this week’s results will show Praised for preventing hundreds of thousands […]
AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021
Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 […]
Why Are Women and Men So Different in Autoimmune Disease?
That last post on vaccine reactions mentioned autotimmune disease several times, and that brings up a question that’s been outstanding for many decades now. If […]
Oxford drugs firm gains $1.5m Gates grant for Covid-19 therapy
Exclusive: Exscientia to use AI in proposed fast-track development of ‘low-cost’ pill for Sars viruses Coronavirus – latest updates See all our coronavirus coverage Exscientia, […]
Million Pfizer jabs face being dumped after Israel-UK swap deal fails
Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July Coronavirus – latest updates See all our coronavirus coverage […]
What mRNA is Good For, And What It Maybe Isn’t
The huge success of the mRNA vaccination platform during the pandemic has set a lot of people to thinking about what comes next. Moderna and […]
The Oxford vaccine: the trials and tribulations of a world-saving jab
Amid bemusement from scientists at the deluge of often undeserved criticism, the Guardian pieces together the story behind the vaccine’s successes and failures Coronavirus – […]
Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy
Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude […]
Western countries must share Covid vaccines – if only for the sake of their GDP
Optimistic forecasts about ‘bouncing back’ will only come true if new variants do not close borders and devastate trade again Coronavirus – latest updates See […]
Covid jabs for billions of humans will earn their makers billions of dollars
We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive […]
Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told
G7 summit hears move would slash the cost of jabs and accelerate the rollout of programmes across the developing world Britain and Germany were last […]
More research funding needed to avoid drug-resistant pandemic, warns report
Smaller firms are developing most antibiotics targeting superbugs but often at risk of bankruptcy Small drugmakers and biotech firms that are developing the bulk of […]
Japan approves two more COVID vaccines as fourth infection wave hits
Japan has approved two more coronavirus vaccines, while expanding a state of emergency to cover the southern island of Okinawa. The two newly approved vaccines […]
Sanofi/GSK move latecomer COVID-19 shot into phase 3
Sanofi and GlaxoSmithKline seem to be getting somewhere with their COVID-19 vaccine at last, announcing plans to move to phase 3 following supportive mid-stage trial […]
Delay in giving second jabs of Pfizer vaccine improves immunity
Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our […]
Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety
The pharmaceutical giant argues waiving intellectual property protections could see scarce inputs snapped up making it harder to produce vaccines Full Story podcast: Is Australia […]
Integration Into the Human Genome?
I’ve had several requests for comment on this recent PNAS paper, which talks about integration of SARS-CoV-2 sequences into the DNA of human cells. I’m […]
EU wants to mass produce three ‘course-changing’ Covid drugs from October
Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid Coronavirus – latest updates See all our coronavirus coverage Three Covid […]
India wants access to cheap copies of Covid vaccines. So why is Australia holding out?
More than 100 countries are pushing for a temporary waiver of IP rules to boost vaccine access for developing nations. Why hasn’t it been approved? […]
Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy
Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results showing its experimental malaria shot could be […]
What Covid vaccines does the UK have and which are in the works?
As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See […]
In the fight against Covid, have we been inoculated against compassion? | Letters
Dr Mohga Kamal-Yanni says world leaders must stop putting big pharma’s profits before people’s lives. Sue Hoar wonders why more is not being done to […]
The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi
Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical […]
Great Malaria Vaccine News
Excellent news today: we have word of the most effective malaria vaccine yet discovered. A year-long trial in Burkina Faso has shown 77% efficacy, which […]
Moderna’s Upcoming Clinical Trials
One of the ways in which this pandemic will be looked back on as a pivot point will (almost certainly) be in the use of […]
Three Advantages of LTACHs: Research Strongly Suggests That LTACHs Play an Important Role as Post-Acute Partners
<div class="right-align"> <a class="btn btn-blue _gt" data-category="Hospital" data-action="Click-Button" data-label="Blog-Three Advantages of LTACHs" href="https://www.kindredhealthcare.com/docs/default-source/default-document-library/hd-three-advantages-of-ltachs.pdf?sfvrsn=44449eea_2" title="Three Advantages of LTACHs: Research Strongly Suggests That LTACHs Play an Important […]
Three Advantages of LTACHs: Research Supports the Important Role LTACHs Play as Post-Acute Partners
<div class="right-align"> <a class="btn btn-blue _gt" data-category="Hospital" data-action="Click-Button" data-label="Blog-Three Advantages of LTACHs" href="https://www.kindredhealthcare.com/docs/default-source/default-document-library/hd-three-advantages-of-ltachs.pdf?sfvrsn=44449eea_2" title="Three Advantages of LTACHs: Research Strongly Suggests That LTACHs Play an Important […]
Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’
Analysis rebuts claim by Boris Johnson that jab was developed ‘because of greed’ Coronavirus – latest updates See all our coronavirus coverage At least 97% […]
Will Covid vaccines protect us against new variants? | Julian Tang
New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do […]
UK strategy of backing several Covid vaccines seems to be paying off
Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage […]
EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay
Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage […]
England begins Moderna vaccine rollout as lockdown eases
England is beginning its rollout of the Moderna COVID-19 vaccine, offering an alternative to the AstraZeneca/Oxford University jab following a potential link to a very […]
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial
Antios has raised $96 million in Series B financing to support the ongoing phase 2 development of its hepatitis B drug candidate, ATI-2173. There are […]
African health workers left without Covid jabs as paltry supplies dwindle
Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage […]
South African variant may evade Pfizer/BioNTech vaccine, study finds
The coronavirus variant discovered in South Africa may evade Pfizer/BioNTech’s vaccine, according to a real-world data study conducted in Israel. Known as variant B.1.351, the […]
Regeneron to ask FDA to use antibody to prevent COVID-19
Regeneron is to ask the FDA for clearance to use its antibody cocktail as a preventive treatment for COVID-19. The therapy is already authorised by […]
Global Covid vaccine rollout threatened by shortage of vital components
Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our […]
AstraZeneca jab worry may play into hands of anti-vaxxers, say Tories
Iain Duncan Smith, former leader, and another MP, warn of eroded confidence in vaccine plan after ‘messy’ MHRA advice Coronavirus – latest updates See all […]
Medicines watchdog says no decision made AstraZeneca jab for under-30s
Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The […]
Blood clot cases ‘could dent faith of young women in AstraZeneca’
Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are […]
Two new vaccines on the way – with more to follow this year
Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our […]
Canada suspends use of AstraZeneca Covid vaccine for those under 55
Immunisation panel says there is ‘substantial uncertainty about the benefit’ of the vaccine given risk of rare type of blood clot See all our coronavirus […]
Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn
The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of […]
How the AstraZeneca vaccine became a political football – and a PR disaster
Newly accused of data manipulation by the US, AstraZeneca has faced unprecedented scrutiny over the past six months Coronavirus – latest updates See all our […]
Regeneron’s antibody cocktail cuts COVID hospitalisation in large trial
Regeneron has posted findings from a large trial its COVID-19 antibody cocktail showing it reduced risk of hospitalisation or death by 70%. The US pharma […]
Pfizer begins clinical trials of COVID-19 antiviral pill
Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection. The company […]
The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial
Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to […]
Vaccine wars: the week that rocked the UK’s Covid jab rollout
After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast […]
France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France […]
France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France […]
Patrick Vallance: the adviser who spoke scientific truth to power
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick […]
Patrick Vallance: the adviser who spoke scientific truth to power
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick […]
Could a smartphone cough app stop future pandemics?
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea […]
Could a smartphone cough app stop future pandemics?
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea […]
Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following […]
Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA
European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage […]
Ireland suspends AstraZeneca Covid vaccine over blood clot concerns
Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of […]
Pharma poised to cash in on ‘long COVID’ symptoms
While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time. According […]
At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot
The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – […]
From Pfizer to Moderna: who’s making billions from Covid vaccines?
The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus […]
‘Vaccine, vaccine’: Dolly Parton urges Americans to get COVID-19 shots
Efforts to encourage US citizens to take their COVID-19 vaccines received a boost from country music legend Dolly Parton, who updated her hit song “Jolene” […]
Genetic Vaccine Development for Infectious Diseases Summit
The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of […]
Covid: Germany and France under pressure to shift Oxford vaccine
Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in […]
Germany signals AstraZeneca vaccine may be approved for over-65s
Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates Coronavirus – latest updates See all […]
Altimmune begins trial of nasal vaccine for COVID-19
Pfizer/BioNTech’s mRNA vaccine against COVID is a technical marvel – but the ultra-cool temperatures required for storage and stability has been tricky to handle. Maryland, […]
Pfizer files tick-borne encephalitis shot with FDA
Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is […]
German politicians counter AstraZeneca vaccine scepticism with show of support
Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our […]
Novavax provides 1.1 billion COVID shots to global vaccine drive
Novavax has signed a deal to provide 1.1 billion doses of its COVID-19 vaccine to the COVAX global initiative led by Gavi, the vaccine alliance, […]
Could CRISPR cure HIV? US biotech Excision raises $60m to find out
US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out […]
South Africa leads backlash against big pharma over access to Covid vaccines
Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major […]
GSK expands coronavirus antibody tie-up to include potential flu therapies
GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The big UK pharma […]
Guinea declares Ebola epidemic following first deaths since 2016
Guinea has officially declared it is dealing with an Ebola epidemic, after at least three people died from the virus. The BBC reported that these […]
UK government mulls lockdown review as it hits 15m COVID vaccine target
More than 15 million people in the UK have had their first coronavirus vaccine, described as a ‘significant milestone’ by prime minister Boris Johnson. While […]
Life savers: the amazing story of the Oxford/AstraZeneca Covid vaccine
A year ago, two scientists began work on the response to a new virus. Now, as their vaccine is being given to millions, they tell […]
‘It shows what we’re capable of’: the NHS’s vaccine triumph
A huge effort has helped the UK provide 14m first doses of Covid vaccines in about two months Coronavirus – latest updates See all our […]
AZ’s next-generation COVID-19 vaccine could be ready in autumn
AstraZeneca is aiming to get a next-generation vaccine targeting emerging variants approved and into the arms of patients by the autumn, company representatives said in […]
FDA grants emergency licence for Lilly’s COVID-19 antibody combo
The FDA has granted an emergency licence for Eli Lilly’s COVID-19 antibody combination therapy, to reduce chances of high-risk patients progressing from mild to moderate […]
EU finalises order for 300 million more Pfizer/BioNTech COVID-19 shots
The European Union has rubber-stamped its order for a further 300 million doses of Pfizer/BioNTech’s COVID-19 vaccine, according to press reports. Citing a European Commission […]
A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence
From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest […]
US experts trial AZ’s long-acting COVID-19 antibody combination
An international trial led by US experts is to begin testing AstraZeneca’s long-acting antibody combination therapy to treat COVID-19. The combination known as AZD7442 is […]
China approves Sinovac’s coronavirus vaccine
China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the second vaccine approved by China’s National Medical […]
Oxford Covid vaccine 10% effective against South African variant, study suggests
Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage […]
Oxford Covid vaccine just as effective against Kent variant, trials suggest
Scientists behind AstraZeneca vaccine say it has similar efficacy against variant as against original Covid Coronavirus – latest updates See all our coronavirus coverage The […]
Veklury rescues Gilead from COVID doldrums in Q4
Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry on two HIV drugs, according to its […]
J&J asks FDA for emergence clearance for single-shot COVID-19 vaccine
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for an Emergency Use Authorization (EUA). The EUA […]
UK reaches 10 million landmark with COVID-19 vaccination programme
The UK has reached a major landmark with its COVID-19 vaccination programme, with more than 10 million people receiving their first shot. After almost a […]
One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days
New analysis runs counter to earlier study which suggested one dose may not give adequate protection Coronavirus – latest updates See all our coronavirus coverage […]
GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine
Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to […]
Even with vaccines, we still need treatments for Covid. So what works?
Analysis: death rates in intensive care are falling as doctors identify more ways to help those with the disease Coronavirus – latest updates See all […]
The Covid vaccination row – cartoon
People are dying as AstraZeneca and the EU clash •You can buy your own copy of this cartoon Continue reading…
UK vaccine strategy ‘paying off’ as latest trials boost stockpiles
Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs Coronavirus – latest updates See all our coronavirus coverage Britain has cemented […]
Novavax’s COVID-19 shot effective against UK strain
Novavax’s COVID-19 vaccine could be added to the UK’s growing arsenal of shots against the disease after it showed 89.3% efficacy in a late-stage trial. […]
How effective is the Novavax Covid vaccine and will it work against variants?
Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an […]
How effective is the Novavax Covid vaccine and will it work against variants?
Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an […]
Novavax Covid vaccine shown to be nearly 90% effective in UK trial
UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, […]
AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens
Latest round of crunch talks to discuss breakdown in supplies still happening, says spokesman Coronavirus – latest updates See all our coronavirus coverage A row […]
Regeneron and Lilly post new data backing COVID antibody cocktails
Regeneron is considering an emergency filing for its antibody cocktail REGEN-COV to protect people against COVID-19 after early trial results showed it conferred 100% protection […]
Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU
Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall Coronavirus – latest updates See all our […]
EU means business over Covid vaccine exports, says Von der Leyen
Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means […]
Pharmaceutical giants not ready for next pandemic, report warns
Ten of the world’s most infectious diseases identified by the WHO not being catered for by drug firms The world’s biggest pharmaceutical firms are little […]
German government challenges AstraZeneca Covid vaccine efficacy reports
Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65 The German government has challenged […]
Germany to administer Covid drugs used to treat Donald Trump
Country will be first in EU to use antibody cocktails after government buys 200,000 doses Specialist clinics in Germany will this week become the first […]
Vaccine experts call for clarity on UK’s 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place […]
Vaccine experts call for clarity on UK’s 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place […]
I’ve had my first vaccine jab. It gives me hope of liberation… but not yet
Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific […]
Vaccine experts defend UK decision to delay second Pfizer Covid jab
Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading […]
World’s poor need action, not Covid ‘vaccine nationalism’, say experts
Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more […]
ViiV/J&J’s long-acting HIV regimen finally approved in US
The FDA has approved Cabenuva, a long-acting HIV treatment from ViiV and Johnson & Johnson that keeps the virus at bay with a monthly injection […]
ConserV Bioscience works on mutation-proof coronavirus shots with US lab
UK biotech ConserV Bioscience has joined with California’s Lawrence Livermore National Laboratory to develop broad-spectrum coronavirus vaccines as concerns mount over potentially more infectious strains […]
Single Covid vaccine dose in Israel ‘less effective than we hoped’
Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that […]
ViiV launches digital triage service for HIV patients with London hospital
ViiV Healthcare and London’s Westminster Hospital NHS Foundation Trust have launched a digital triage service for HIV patients supported by a mobile app. ViiV, a […]
Fauci backs Biden’s plan for 100 million COVID-19 shots
A promise by president-elect Joe Biden to carry out 100 million coronavirus vaccinations in his first 100 days in power is “absolutely doable”, according to […]
UK to face short term delay in delivery of Pfizer vaccine
Overall number of doses delivered between January and March will remain the same, the firm says Coronavirus – latest updates See all our coronavirus coverage […]
Tivicay approved in Europe in new dispersible tablet for children with HIV
ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living with HIV. The joint venture, majority-owned by […]
Study says COVID-19 infection provides immunity, but people can transmit virus
Previous COVID-19 infection provides some immunity for at least five months, but people may still carry and transmit the virus, according to a study by […]
Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns
Australia has secured 54m doses of the vaccine some experts say is inferior to Pfizer’s mRNA vaccine, which Australia has bought just 10m doses of […]
Pfizer/BioNTech vaccine may work against new virus mutation, scientists say
The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to […]
UK left trailing as EU quickly approves Moderna’s COVID-19 vaccine
The European Union has approved the coronavirus vaccine from Moderna, leaving the UK trailing because of changes to post-Brexit drug approval rules. With the UK […]
Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty
The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security […]
UK vaccine minister vows ‘massive uplift’ in number of jabs this week
Nadhim Zahawi says ‘absolute focus’ is to get 13.9 million people inoculated by mid-February Coronavirus – latest updates See all our coronavirus coverage The UK […]
How is the Oxford Covid vaccine being deployed in England?
With jab to be administered to public for first time, we look at key questions about its rollout Coronavirus – latest updates See all our […]
The Oxford Covid jab is delivered this week. But when will vaccines bring results?
Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain […]
What difference will Oxford/AstraZeneca vaccine make in UK?
We look at how the introduction of a new vaccine in the fight against Covid will work Coronavirus – latest updates See all our coronavirus […]
Change in vaccine policy is a high-stakes gamble | Letters
The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren […]
Questions hang over UK’s rollout of Oxford/AstraZeneca jab
Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all […]
UK prepares for decision on AZ/Oxford vaccine as COVID cases soar
The UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make a decision on a shot from Oxford […]
Government ‘operated illegal buy British policy’ over Covid contracts
Other firms better placed to supply antibody tests, argues case against health secretary Matt Hancock Coronavirus – latest updates See all our coronavirus coverage The […]
NHS pilots virtual assistant for flu jab bookings
More than 1,000 NHS patients have booked flu vaccinations using a virtual assistant as part of a pilot project in the south east of England. […]
FDA aims for fast approval of Moderna’s COVID-19 shot after panel vote
The FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel of experts. Yesterday’s advisory panel meeting voted […]
British American Tobacco wins approval to test Covid vaccine on humans
Treatment grown on tobacco plants gets US backing for clinical study Coronavirus – latest updates See all our coronavirus coverage British American Tobacco has moved […]
Scheme to get Covid vaccine to poorer countries at ‘high risk’ of failure
Risk assessment documents say cost, delays and shortages could lead to billions not vaccinated until 2024 Coronavirus – latest updates See all our coronavirus coverage […]
AbbVie begins trials of COVID-19 antibody therapy
AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht […]
Family doctors begin COVID-19 immunisation drive in UK
The roll-out of the biggest vaccination programme in the history of the UK’s NHS is gathering pace, as family doctors and their teams begin taking […]
Novartis/Incyte draw blank with Jakafi in COVID-19
Novartis/Incyte’s Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against COVID-19, after it failed to cut complications […]
FDA advisers vote in favour of Pfizer/BioNTech COVID-19 shot
Advisers to the FDA have voted in favour of approving Pfizer and BioNTech’s COVID-19 vaccine, with a near-unanimous backing from an expert committee. While the […]
Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi
The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates […]
NHS told not to give Pfizer vaccine to extreme allergy sufferers after two people have reaction
Anyone scheduled to receive vaccine will be asked about history of allergic reactions Coronavirus – latest updates See all our coronavirus coverage Regulators have issued […]
FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that […]
Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines
Billions unlikely to get jabs as rich countries secure 53% of most promising vaccines Coronavirus – latest updates See all our coronavirus coverage Nine out […]
Leaders in the Life Sciences Speak about the Pandemic
We are in a global pandemic that is exposing major issues in the commercial environment in which healthcare companies operate, with changes that are completely altering […]
FDA: Pfizer Covid vaccine data fits with guidance on emergency authorization
Comments raise hopes that the vaccine could soon be available to Americans aged 16 and above US Food and Drug Administration (FDA) staff said on […]
First COVID-19 vaccinations begin in UK hospitals
A 90-year-old woman has become the first person given a COVID-19 vaccine as part of the UK’s mass vaccination programme. Margaret Keenan was given the […]
Valneva accelerates Lyme disease vaccine R&D project with Pfizer
Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter […]
PureTech begins trial of potential ‘Long COVID’ drug as cases mount
As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after the initial infection has been fought off. […]
How does the Pfizer/BioNTech vaccine work and who will get it?
Covid vaccine with an efficacy of almost 95% has been authorised by the UK medicines regulator Coronavirus – latest updates See all our coronavirus coverage […]
Oxford controversy is the first shot in international battle over vaccine efficiency
Trials will not reveal all the facts on prevention for each new drug – that process could last for years Coronavirus – latest updates See […]
Different age groups may get different Covid vaccines, experts say
Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage […]
BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn
Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the […]
Will everyone in the world have access to a Covid vaccine? – video explainer
The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed […]
‘Mistake’ led to AZ’s more effective lower-dose COVID-19 shot
AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident. According to Reuters, the AstraZeneca development […]
FDA approves Roche’s Xofluza to prevent flu spreading in families
The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people developing flu after coming into contact with […]
‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data
Trial participants react to news that Oxford AstraZeneca Covid vaccine has up to 90% efficacy Coronavirus – latest updates See all our coronavirus coverage Dan […]
Oxford AstraZeneca results open up Covid vaccine to developing countries
Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our […]
The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial
Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They […]
Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn
No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates […]
Trials to begin in UK for Covid antibody cocktail drug treatment
Scientists say jab could be used to protect those who cannot be given vaccines Coronavirus – latest updates See all our coronavirus coverage Major trials […]
UK faces calls to drop opposition to patent-free Covid vaccines
Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The […]
Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows
Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus […]
ViiV could challenge Gilead with long-acting HIV PrEP shot
GlaxoSmithKline’s HIV joint venture ViiV Healthcare could mount a challenge to Gilead’s HIV pre-exposure prophylaxis (PrEP) medicines after the FDA granted Breakthrough Therapy Designation for […]
COVID-19: Helping to support momentum on antimicrobial innovation
To mark World Antimicrobial Awareness Week NovaBiotics’s Deborah O’Neil tells us why 2021 might be the year anti-infective drugs finally demonstrate their economic value. COVID-19 […]
UK in ‘advanced discussions’ to buy Moderna Covid vaccine
Britain decided not to buy US vaccine and earliest it could be supplied to UK is spring 2021 Coronavirus – latest updates See all our […]
It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff
To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See […]
Moderna Covid vaccine candidate almost 95% effective, trials show
US-based biotech firm is latest to reveal impressive results from phase 3 trials of jab Coronavirus – latest updates See all our coronavirus coverage The […]
BioNTech vaccine scientist says jab could halve Covid transmission
Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The […]
Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik
Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a […]
Lilly’s Monoclonal EUA
I’ve been meaning to write about what has to be called a regulatory mystery. Eli Lilly obtained an Emergency Use Authorization for its monoclonal antibody […]
BioNTech chief rejects Trump claim it delayed Covid vaccine news
Exclusive: Ugur Şahin says he and Pfizer CEO received results night before announcement Coronavirus – latest updates See all our coronavirus coverage The scientist behind […]
The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones
The pharmaceutical industry has long made exorbitant profits by free-riding on research carried out by the public sector Hooray for Pfizer! As news of a […]
Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury
Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week […]
Where will poorer countries stand in the queue for a Covid-19 vaccine? | Clare Wenham and Mark Eccleston-Turner
The lion’s share of the potential Pfizer vaccine is already claimed by high-income nations The news that joint efforts by the US pharmaceutical company Pfizer […]
Good News on T-Cell Response
There are several recent preprints and publications that bear on the T-cell immunity story for the coronavirus pandemic, and I wanted to highlight these, since […]
Pfizer and BioNTech could make $13bn from coronavirus vaccine
Johnson & Johnson and AstraZeneca pledged to make their vaccines available on a not-for-profit basis Coronavirus – latest updates See all our coronavirus coverage The […]
Pfizer and BioNTech’s vaccine poses global logistics challenge
Europe and US create vast facilities for Covid-19 vaccine but poorer nations lack infrastructure say experts Coronavirus – latest updates See all our coronavirus coverage […]
The Guardian view on the Covid vaccine breakthrough: making it work | Editorial
At last, there is hope of an end to this pandemic. Scientists appear to have performed an amazing feat, the rest of us must do […]
Will enough people in the UK take the Covid-19 jab?
The UK usually has a high take-up for vaccines, experts say, but there are fears over misinformation and scepticism Coronavirus: anti-vaxxers seek to discredit Pfizer’s […]
Cautious optimism over Covid-19 vaccine trials | Letters
Readers respond to news that an interim analysis has shown Pfizer/BioNTech’s vaccine candidate was 90% effective in protecting people from transmission of the virus in […]
6 key questions about the Pfizer/BioNTech Covid-19 vaccine
There are grounds for optimism but also several unknowns around this coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage Hopes that the […]
What does the Pfizer Covid vaccine breakthrough mean for Australia?
Interim results show vaccine to be 90% effective, but findings have not been peer-reviewed, Australia has only secured enough for five million people, and there […]
Don’t Make Mine Mink
There’s a situation in Denmark that deserves some epidemiological attention. Now, put me in the (rather large) category who did not realize how large the […]
UK could get COVID-19 vaccines early next year, ahead of European countries
COVID-19 vaccines could be approved and available early next year in the UK ahead of European countries, after its national regulator began its own rolling […]
Regeneron’s COVID-19 antibody cocktail therapy hits safety problem
Regeneron’s coronavirus antibody cocktail therapy against COVID-19, famously used to treat president Donald Trump, has hit a safety issue after independent safety experts recommended it […]
Oxford Covid vaccine works in all ages, trials suggest
Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups Coronavirus – latest updates See all our coronavirus coverage One of […]
Are we near to having a vaccine for Covid-19?
Even a once bullish PM is now not so optimistic but there are promising signs of a vaccine on the horizon Coronavirus – latest updates […]
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
Gilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in a large global trial, casting doubt on […]
Regeneron’s antibody cocktail approved by FDA for Ebola
An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering hope that a similar approach could be […]
Coronavirus re-infection case confirmed in the US
There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in […]
NHS coronavirus tests threatened by Roche supply chain glitch
Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs Coronavirus – latest updates See all our coronavirus coverage Concerns have been […]
Trump’s steroid Covid treatment adds to confusion over health
Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team […]
Anti-Covid treatments being given to Trump are still unproven, say experts
Neither remdesivir nor REGN-COV2 have completed large-scale randomised trials, say UK scientists Coronavirus – latest updates See all our coronavirus coverage Scientists still lack conclusive […]
UK doing more than most to help poor get Covid vaccine, study finds
Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing […]
Interferon and the Coronavirus
Here’s a potentially important paper that’s out in Science and is getting a lot of attention. The wide variation in severity of coronavirus infection has […]
Pharmacies in England pause online flu jab bookings as demand soars
Boots, LloydsPharmacy and Well Pharmacy report unprecedented take-up and many chemists run out of stock Coronavirus – latest updates See all our coronavirus coverage Pharmacies […]
Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes
Healthcare workers and health departments will be among the first to use the rapid antigen tests Full Australian Covid stats; Covid restrictions state by state […]
Monoclonal Antibody Data
We have a bit of human clinical data from the Eli Lilly/Abcellera collaboration to make a monoclonal antibody therapy against the coronavirus. A full paper […]
Beware of big pharma in rush for Covid-19 vaccine | Letter
Heidi Chow on why the pharmaceutical industry must not be left in the driving seat to supply an effective Covid-19 vaccine The biggest gamble that […]
Show more empathy to boost confidence in vaccines, scientists told
Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in […]
Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief
Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still […]
Oxford Covid vaccine trial suspension: what happens next?
Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure? The AstraZeneca vaccine trial has been […]
